Reply to Letter to the Editor "Continuing Dialogue on Incentive Bias"
J Clin Psychiatry 1997;58(10):452 [letter]
© Copyright 2015 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Letter to the Editor
Sir: There is little doubt that it makes sense and is right for readers of The Journal of Clinical Psychiatry (JCP) or for that matter, any journal, to be aware that a journal supplement is supported by an unrestricted educational grant from the pharmaceutical industry. I take no issue with this recommendation and heartily endorse it.
However, I do take issue with several of the other comments made by Jefferson, Greist, and Katzelnick in the space above. In particular, I take strong exception to the implication that my article published in JCP was influenced by a pharmaceutical sponsor. This is simply not the case, and frankly I am surprised that such experienced psychopharmacologists as Jefferson and Greist would take such a position.